Patient tumor tissue samples as well as ovarian cancer cell lines show relatively consistent protein levels regardless of ADRM1 mRNA expression levels suggesting that RPN13 expression is heavily post-transcriptionally regulated. The gene discussed is ADRM1; the disease is ovarian carcinoma.